key: cord-0748300-pgtvx6wb
authors: Ye, Feng; Xu, Shicai; Rong, Zhihua; Xu, Ronghua; Liu, Xiaowei; Deng, Pingfu; Liu, Hai; Xu, Xuejun
title: Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster
date: 2020-04-02
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.03.042
sha: af0e6df2898b3f5de78f6f15e493c89b4bc283ec
doc_id: 748300
cord_uid: pgtvx6wb

OBJECTIVES: With the ongoing outbreak of COVID-19 around the world, it has become a worldwide health concern. One previous study reported a family cluster with asymptomatic transmission of COVID-19. Here, we report another series of cases and further demonstrate the repeatability of the transmission of COVID-19 by pre-symptomatic carriers. METHODS: A familial cluster of five patients associated with COVID-19 was enrolled in the hospital. We collected epidemiological and clinical characteristics, laboratory outcomes from electronic medical records, and also affirmed them with the patients and their families. RESULTS: Among them, three family members (Case 3/4/5) had returned from Wuhan. Additionally, two family members, those who had not travelled to Wuhan, also contracted COVID-19 after contacting with the other three family members. Case 1 developed severe pneumonia and was admitted to the ICU. Case 3 and Case 5 presented fever and cough on days 2 through 3 of hospitalization and had ground-glass opacity changes in their lungs. Case 4 presented with diarrhoea and pharyngalgia after admission without radiographic abnormalities. Case 2 presented no clinical or radiographic abnormalities. All the cases had an increasing level of C-reactive protein. CONCLUSIONS: Our findings indicate that COVID-19 can be transmitted by asymptomatic carriers during the incubation period.

On Dec 31, 2019, the government of Hubei Province, China, first reported a J o u r n a l P r e -p r o o f group of confused patients with pneumonia [1] . Metagenomics sequencing analysis revealed a novel coronavirus, which was officially named SARS-CoV-2 and is the cause of the disease named COVID-19 [2] . The National Health Commission (NHC) set COVID-19 as a category B infectious disease with A-class management on Jan 20 [1] . Furthermore, on Jan 30, the WHO issued a Public Health Emergency of International Concern (PHEIC) alarm and appealed all specialists over the world working together to control the rapid spread of COVID-19. As of Mar 8, there had been 80,859 confirmed patients of COVID-19 in China, including 3,100 deaths.

Internationally, over 100 countries have now reported laboratory-confirmed cases, including a total of 24,031 cases [3] .

The first clinical data from 41 individuals with a confirmed diagnosis of COVID-19 from Wuhan, China, have been published [4] . Most of them had been directly exposed to the Wuhan seafood wholesale market, which sells freshly slaughtered game animals, that were the original infection source [4] . The present data strongly suggest that game animals or mammals were probably intermediate hosts of SARS-CoV-2 that originated from the Chinese horseshoe bat [5, 6] . In addition, the virus has preferential tropism to human airway epithelial cells through the same cellular receptor as that for SARS, angiotensin-converting enzyme 2(ACE2), which is a central body receptor for the surface glycoprotein S of the virus [7] . The way to ascertain disease depends on positive real-time reverse transcription-polymerase chain reaction(rRT-PCR) results for SARS-CoV-2 nucleic acid, and the associated mortality rates are 2-3% [3, 8] . Currently, there are no definite antiviral therapies or vaccines for J o u r n a l P r e -p r o o f 5 COVID-19, although some drugs are under investigation.

With the extensive outbreak of COVID-19, a mass of studies with a larger population have been reported. Obviously, the total number of cases and transmission events have far exceeded those of SARS and H1N1. Wu et al. [9] found that the mean R0 of COVID-19 was approximately 2.68(95% CI: 2.47-2.86). An increasing number of outbreaks of familial transmission stressed the possibility of person-to-person transmission [10] [11] [12] . The measures in which public health officials quarantine confirmed cases and isolate intimate patients are significant progress in responding to COVID-19 control. Another question for consideration is a group of asymptomatically infected individuals, which may propagate the virus and impede infection control [5, 13] . Bai et al. [14] presented clinical data showing a familial cluster of 5 patients with COVID-19 and 1 asymptomatic family member, which presumed the possibility of infection from asymptomatic carriers.

In this study, we report the clinical features of a family cluster involving five COVID-19 cases in Luzhou. Three cases came from Wuhan, and the other two cases had not left Luzhou recently. Our data further verified the delivery of infection from asymptomatic carriers of COVID-19 during the incubation period. Subsequently, forty-four other intimate contacts were admitted to our hospital for general physical examination on Feb 5. The local CDC ascertained that the nasopharyngeal or oropharyngeal swabs were positive for 4 cases(Case 2/3/4/5) according to SARS-CoV-2 nucleic acid tests( Table 2 ). All cases were enrolled in hospital and treated in isolation. A detailed data collection for the five patients was executed, and all patients underwent chest CT imaging. All the laboratory procedures for clinical samples have been previously reported [15] . Nasopharyngeal and oropharyngeal swabs and stool and urine samples were obtained and maintained viral transport medium. Plasma was separated from EDTA bottles, and serum was separated from clotted blood bottles. Specimens were placed between 2°C and 8°C and sent to the CDC. RRT-PCR tests for SARS-CoV-2 nucleic acid were performed by the local CDC, , and the detection reagents were from Maccura Biotechnology Co.,Ltd and Sansure Biotechnology Co.,Ltd.

The Ethics Committee of the People's Hospital of Luxian County approved this study. We obtained written consent from all the patients about clinical data, radiographic pictures, information, etc.

We documented and analysed the clinical symptoms, laboratory results, and history of five cases with verified COVID-19, as presented in Table 1 . The relationship between the 5 cases and their general information are shown in Figure 3 . (Table 2) . Case 2, a 28-year-old man, was living in Luzhou. He had not come to an area where COVID-19 was spreading or had contact with any fever or pneumonia patients.

He had just attended the family reunion dinner with his family members, including his mother (Case 1)/uncle(Case 3)/aunt(Case 4)/cousin(Case 5) on Jan 23 through 25.

After the diagnosis of COVID-19, he never had an elevated temperature, and there were no abnormal symptoms except an increasing level of C-reactive protein (Table 1 ) and increasing C-reactive protein (9.0/24.7 mg/L). Their infections were moderate. Although their symptoms had resolved except cough, they remained hospitalized because their rRT-PCR test results were positive as of Feb 15 (Table 2 ).

COVID-19 has been proven to be transmitted through the respiratory tract, digestive system, and mucosal surfaces(such as the conjunctiva) [10, 16] . Nosocomial infections in healthcare facilities also occur and highlight the significance of effective infection control [13] . At the onset, the symptoms are usually fever, cough, shortness of breath and pharyngalgia or diarrhoea [17] . The emblematic radiologic characteristic is ground-glass opacities in the lungs. Laboratory data present as lymphocytopenia, hypoxemia, thrombocytopenia, and even liver and kidney dysfunction in severe pneumonia patients [4] . At present, verified patients are the primary sources of infection, while asymptomatic carriers can also be a source to propagate the outbreak. These patients are not easy to detect when initially infected but might have abnormal symptoms later [4] .

In this familial cluster of five patients associated with COVID-19 in Luzhou, China, Case 1 had contact with only her family members(Case 2/3/4/5), some of them must be asymptomatic carriers of COVID 19. It was certain that Case 2 through 5 had no abnormal symptoms before the outbreak of Case 1. Notably, COVID-19 is highly J o u r n a l P r e -p r o o f infectious, and may be transmitted by asymptomatic carriers during the incubation period. The timeline events suggest that Case 4 was the most likely initial infection source, as the time of the onset of symptoms and negative rRT-PCR results was relatively earlier than Case 3 and Case 5 (Figure 2 ). Case 2 was afebrile without any clinical signs, and his chest CT images showed no abnormalities on Feb 5 and Feb 15 (Figure 1 ), which also proved the existence of asymptomatic carriers. Our findings provide evidence that asymptomatic carriers can be a latent source of COVID-19 infection. As the spread of COVID-19 is aggravating worldwide, it is pressing to provide more meritorious information for an improved understanding of the transmission and precaution of COVID-19. Further studies on the mechanism in which asymptomatic carriers can acquire and transmit COVID-19 are warranted.

All of the authors collected epidemiological and clinical data and discussed the results. 

This work was not funded and did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

The Ethics Committee of People's Hospital of Luxian County approved this study. We obtained written consent from all the patients about clinical data, radiographic pictures, information, etc.

for editing this manuscript.

All data and materials used in this work are publicly available.

J o u r n a l P r e -p r o o f 

The Central Government of the People's Republic of China

World health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11

World Health Organization

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet

A novel coronavirus emerging in China-key questions for impact assessment

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

A person-to-person transmission: a study of a family cluster

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

Importation and human-to-human transmission of a novel coronavirus in Vietnam

The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes

Presumed Asymptomatic Carrier Transmission of COVID-19

Viral load in patients infected with pandemic H1N1 2009 influenza A virus

Consistent detection of 2019 novel coronavirus in saliva

National Health Commission of the People's Republic of China. Diagnosis and treatment of novel coronavirus infected pneumonia (The sixth edition)

The authors would like to acknowledge the Luzhou CDC for performing SARS-CoV-2 nucleic acid tests, and thank AJE Editing Service (https://www.aje.com)

The authors declare that there are no conflicts of interest.

No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. We all read "Instructions to Authors" and comply with those instructions and accept the conditions posed. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. If the paper is accepted, it will not be published elsewhere in the same form, in English or in any other language, without written consent of the copyright holder.